386 related articles for article (PubMed ID: 16145534)
21. Advances in meningioma therapy.
Norden AD; Drappatz J; Wen PY
Curr Neurol Neurosci Rep; 2009 May; 9(3):231-40. PubMed ID: 19348712
[TBL] [Abstract][Full Text] [Related]
22. Current treatment options for meningioma.
Apra C; Peyre M; Kalamarides M
Expert Rev Neurother; 2018 Mar; 18(3):241-249. PubMed ID: 29338455
[TBL] [Abstract][Full Text] [Related]
23. Intracranial meningiomas: an overview of diagnosis and treatment.
Rockhill J; Mrugala M; Chamberlain MC
Neurosurg Focus; 2007; 23(4):E1. PubMed ID: 17961033
[TBL] [Abstract][Full Text] [Related]
24. Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence.
Bollag RJ; Vender JR; Sharma S
Neuropathology; 2010 Jun; 30(3):279-87. PubMed ID: 19780983
[TBL] [Abstract][Full Text] [Related]
25. Osteopontin predicts the behaviour of atypical meningioma.
Lin CK; Tsai WC; Lin YC; Hueng DY
Histopathology; 2012 Jan; 60(2):320-5. PubMed ID: 22211290
[TBL] [Abstract][Full Text] [Related]
26. Management of meningeal neoplasms: meningiomas and hemangiopericytomas.
Lamar Z; Lesser GJ
Curr Treat Options Oncol; 2011 Sep; 12(3):230-9. PubMed ID: 21537847
[TBL] [Abstract][Full Text] [Related]
27. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
van de Nes JA; Griewank KG; Schmid KW; Grabellus F
Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
[TBL] [Abstract][Full Text] [Related]
29. Meningiomas.
Whittle IR; Smith C; Navoo P; Collie D
Lancet; 2004 May; 363(9420):1535-43. PubMed ID: 15135603
[TBL] [Abstract][Full Text] [Related]
30. The role of radiosurgery in the management of WHO Grade II and III intracranial meningiomas.
Ding D; Starke RM; Hantzmon J; Yen CP; Williams BJ; Sheehan JP
Neurosurg Focus; 2013 Dec; 35(6):E16. PubMed ID: 24289124
[TBL] [Abstract][Full Text] [Related]
31. Meningiomas: Overview and New Directions in Therapy.
Wang N; Osswald M
Semin Neurol; 2018 Feb; 38(1):112-120. PubMed ID: 29548058
[TBL] [Abstract][Full Text] [Related]
32. The role of radiotherapy in the management of high-grade meningiomas.
Hwang KL; Hwang WL; Bussière MR; Shih HA
Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S5. PubMed ID: 28758409
[TBL] [Abstract][Full Text] [Related]
33. Comparative proteomic profiles of meningioma subtypes.
Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z
Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
35. Meningioma.
Marosi C; Hassler M; Roessler K; Reni M; Sant M; Mazza E; Vecht C
Crit Rev Oncol Hematol; 2008 Aug; 67(2):153-71. PubMed ID: 18342535
[TBL] [Abstract][Full Text] [Related]
36. Lipid signal in evaluation of intracranial meningiomas.
Qi ZG; Li YX; Wang Y; Geng DY; Li KC; Shen TZ; Chen XR
Chin Med J (Engl); 2008 Dec; 121(23):2415-9. PubMed ID: 19102960
[TBL] [Abstract][Full Text] [Related]
37. Benign adult brain tumors: an evidence-based medicine review.
Aghi M; Barker Ii FG
Prog Neurol Surg; 2006; 19():80-96. PubMed ID: 17033148
[TBL] [Abstract][Full Text] [Related]
38. Gamma Knife Radiosurgery for Atypical and Anaplastic Meningiomas.
Wang WH; Lee CC; Yang HC; Liu KD; Wu HM; Shiau CY; Guo WY; Pan DH; Chung WY; Chen MT
World Neurosurg; 2016 Mar; 87():557-64. PubMed ID: 26485417
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of EGFR expression in de novo and progressed atypical and anaplastic meningiomas: an immunohistochemical and fluorescence in situ hybridization pilot study.
Caltabiano R; Barbagallo GM; Castaing M; Cassenti A; Senetta R; Cassoni P; Albanese V; Lanzafame S
J Neurosurg Sci; 2013 Jun; 57(2):139-51. PubMed ID: 23486338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
